Literature DB >> 15358595

EGF receptor transactivation mediates ANG II-stimulated mitogenesis in intestinal epithelial cells through the PI3-kinase/Akt/mTOR/p70S6K1 signaling pathway.

Terence Chiu1, Chintda Santiskulvong, Enrique Rozengurt.   

Abstract

The role of epidermal growth factor receptor (EGFR) tyrosine kinase and its downstream targets in the regulation of the transition from the G0/G1 phase into DNA synthesis in response to ANG II has not been previously investigated in intestinal epithelial IEC-18 cells. ANG II induced a rapid and striking EGFR tyrosine phosphorylation, which was prevented by selective inhibitors of EGFR tyrosine kinase activity (e.g., AG-1478) or by broad-spectrum matrix metalloproteinase (MMP) inhibitor GM-6001. Pretreatment of these cells with either AG-1478 or GM-6001 reduced ANG II-stimulated DNA synthesis by approximately 50%. To elucidate the downstream targets of EGFR, we demonstrated that ANG II stimulated phosphorylation of Akt at Ser473, mTOR at Ser2448, p70S6K1 at Thr389, and S6 ribosomal protein at Ser(235/236). Pretreatment with AG-1478 inhibited Akt, p70S6K1, and S6 ribosomal protein phosphorylation. Inhibition of phosphatidylinositol (PI)3-kinase with LY-294002 or mTOR/p70S6K1 with rapamycin reduced [3H]thymidine incorporation by 50%, i.e., to levels comparable to those achieved by addition of either AG-1478 or GM-6001. Utilizing Akt small-interfering RNA targeted to Akt1 and Akt2, Akt protein knockdown dramatically inhibited p70S6K1 and S6 ribosomal protein phosphorylation. In contrast, AG-1478 or Akt gene silencing exerted no detectable inhibitory effect on ANG II-induced extracellular signal-regulated kinase 1/2 phosphorylation in IEC-18 cells. Taken together, our results demonstrate that EGFR transactivation mediates ANG II-stimulated mitogenesis through the PI3-kinase/Akt/mTOR/p70S6K1 signaling pathway in IEC-18 cells.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15358595     DOI: 10.1152/ajpgi.00200.2004

Source DB:  PubMed          Journal:  Am J Physiol Gastrointest Liver Physiol        ISSN: 0193-1857            Impact factor:   4.052


  29 in total

1.  Zinc released from injured cells is acting via the Zn2+-sensing receptor, ZnR, to trigger signaling leading to epithelial repair.

Authors:  Haleli Sharir; Anna Zinger; Andrey Nevo; Israel Sekler; Michal Hershfinkel
Journal:  J Biol Chem       Date:  2010-06-03       Impact factor: 5.157

2.  Rapid protein kinase D1 signaling promotes migration of intestinal epithelial cells.

Authors:  Steven H Young; Nora Rozengurt; James Sinnett-Smith; Enrique Rozengurt
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2012-05-17       Impact factor: 4.052

3.  Protein kinase D1 (PKD1) phosphorylation on Ser203 by type I p21-activated kinase (PAK) regulates PKD1 localization.

Authors:  Jen-Kuan Chang; Yang Ni; Liang Han; James Sinnett-Smith; Rodrigo Jacamo; Osvaldo Rey; Steven H Young; Enrique Rozengurt
Journal:  J Biol Chem       Date:  2017-04-13       Impact factor: 5.157

4.  Early endosomal antigen 1 (EEA1) is an obligate scaffold for angiotensin II-induced, PKC-alpha-dependent Akt activation in endosomes.

Authors:  Rafal Robert Nazarewicz; Gloria Salazar; Nikolay Patrushev; Alejandra San Martin; Lula Hilenski; Shiqin Xiong; R Wayne Alexander
Journal:  J Biol Chem       Date:  2010-11-20       Impact factor: 5.157

Review 5.  ERBBs in the gastrointestinal tract: recent progress and new perspectives.

Authors:  William H Fiske; David Threadgill; Robert J Coffey
Journal:  Exp Cell Res       Date:  2008-11-07       Impact factor: 3.905

6.  Angiotensin II inhibits P-glycoprotein in intestinal epithelial cells.

Authors:  Anoop Kumar; Shubha Priyamvada; Vikas Soni; Arivarasu N Anbazhagan; Tarunmeet Gujral; Ravinder K Gill; Waddah A Alrefai; Pradeep K Dudeja; Seema Saksena
Journal:  Acta Physiol (Oxf)       Date:  2019-07-01       Impact factor: 6.311

7.  Angiotensin II activation of mTOR results in tubulointerstitial fibrosis through loss of N-cadherin.

Authors:  Adam Whaley-Connell; Javad Habibi; Zachary Panfili; Melvin R Hayden; Sarika Bagree; Ravi Nistala; Safwan Hyder; Bennett Krueger; Vincent Demarco; Lakshmi Pulakat; Carlos M Ferrario; Alan Parrish; James R Sowers
Journal:  Am J Nephrol       Date:  2011-06-29       Impact factor: 3.754

Review 8.  Resistance to insulin and kidney disease in the cardiorenal metabolic syndrome; role for angiotensin II.

Authors:  Ravi Nistala; Adam Whaley-Connell
Journal:  Mol Cell Endocrinol       Date:  2013-02-15       Impact factor: 4.102

9.  Metastatic Renal Cancer: What Role for Everolimus?

Authors:  Franck A Belibi; Charles L Edelstein
Journal:  Clin Med Rev Oncol       Date:  2010-02-18

10.  CDC25B mediates rapamycin-induced oncogenic responses in cancer cells.

Authors:  Run-Qiang Chen; Qing-Kai Yang; Bing-Wen Lu; Wei Yi; Greg Cantin; Yan-Ling Chen; Colleen Fearns; John R Yates; Jiing-Dwan Lee
Journal:  Cancer Res       Date:  2009-03-10       Impact factor: 12.701

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.